Leerink Partners sets Teva price target at $45
Leerink Partners announced a $45.00 per-share price target for Teva.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Leerink Partners announced a $45.00 per-share price target for Teva.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.